VOLITIONRX LTD (VNRX) › Cash & EquivalentsVOLITIONRX LTD (VNRX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $47.5K2011: $347.9K2012: $376.4K2014: $2.14M2015: $5.92M2016: $21.68M2017: $10.12M2018: $13.43M2019: $16.97M2020: $19.44M2021: $20.58M2022: $10.87M2023: $20.73M2024: $3.26M2025: $1.12M$1.12M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.12M-65.8%2024$3.26M-84.3%2023$20.73M+90.8%2022$10.87M-47.2%2021$20.58M+5.8%2020$19.44M+14.6%2019$16.97M+26.4%2018$13.43M+32.7%2017$10.12M-53.3%2016$21.68M+266.4%2015$5.92M+176.6%2014$2.14M—2012$376.4K+8.2%2011$347.9K+632.7%2010$47.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share